Share this to:

Support & Insight for the Autumn of Life

New Alzheimer’s Drug Lecanemab: High price tag, Moderate warnings

Mayo Clinic on lecanemab
The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons. (Video)

The Food and Drug Administration (FDA) has granted traditional approval for generic lecanemab (brand name Leqembi®). The new treatment promises to slow the decline of memory and thinking in some Alzheimer’s patients.

Dr. Kavita Patel joined Alicia Menendez on American Voices to discuss the drug’s benefits, risks and what it means for caregivers. 

Lecanemab is a monoclonal antibody that has shown promise in removing amyloid plaques from the brain, according to phase 3 trial results.

See Dr. Ronald Petersen, a neurologist and director of the Mayo Clinic Alzheimer’s Disease Research Center, describe Lecanemab’s therapeutic ability to slow Alzheimer’s by removing amyloid plaques. These plaques are one of the defining features of Alzheimer’s disease.


  • MSNBC YouTube Channel
  • Mayo Clinic YouTube Channel
  • Subscribe
    Notify of

    Inline Feedbacks
    View all comments
    Hanna Levi Julian

    Hanna Levi Julian

    Visit Our Pages On:


    This site was inspired by my Mom’s autoimmune dementia.

    It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

    The site is dedicated to all those preserving the dignity of the community of people living with dementia.

    Peter Berger, Editor


    lab, experiment, test
    PrecivityAD™ Blood Test Helps Diagnose Alzheimer's
    Research shows that a blood test now on the market accurately identifies brain amyloid status with a single blood sam...
    dna, biology, medicine
    The Genetic Factor That Fends Off Alzheimer's
    A massive study of medical and genetic data shows that people with a particular version of a gene involved in immune...
    pillows, sheets, full hd wallpaper
    Alzheimer's Lethargy Due to Neurodegeneration, Not Insomnia
    The tendency of Alzheimer's patients to sleep throughout the day is not due to nighttime insomnia -- it has to do wit...
    Would love your thoughts, please comment.x
    News, Treatments, Care Tips

    Subscribe To The Weekly Newsletter

    videos & articles on Research & Prevention
    News to Get at the Truth

    Subscribe To Our Weekly Newsletter